Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Risk factors of cardiovascular disease among children with chronic kidney disease in Gaza strip.

Muhaisen RM, Sharif FA, Yassin MM.

J Cardiovasc Dis Res. 2012 Apr;3(2):91-8. doi: 10.4103/0975-3583.95360.

2.
3.

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.

Nefrologia. 2008;28 Suppl 3:39-48. Spanish.

4.

Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.

Abdulle AM, Gillett MP, Abouchacra S, Sabri SM, Rukhaimi MA, Obineche EN, Singh J.

Mol Cell Biochem. 2007 Aug;302(1-2):195-201. Epub 2007 Mar 27.

PMID:
17387582
5.

Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.

Afzali B, Bakri RS, Bharma-Ariza P, Lumb PJ, Dalton N, Turner NC, Wierzbicki AS, Crook MA, Goldsmith DJ.

J Nephrol. 2003 Jul-Aug;16(4):540-5.

PMID:
14696756
6.

Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function.

Isbel NM, Haluska B, Johnson DW, Beller E, Hawley C, Marwick TH.

Am Heart J. 2006 Mar;151(3):745-53.

PMID:
16504645
7.

[Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].

Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.

Zhonghua Yi Xue Za Zhi. 2005 Mar 23;85(11):753-9. Chinese.

PMID:
15949381
8.

Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS.

Arch Intern Med. 2006 Sep 25;166(17):1884-91.

PMID:
17000946
9.

Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.

Avila-Díaz M, Matos M, García-López E, Prado MD, Castro-Vázquez F, Ventura MD, González E, Amato D, Paniagua R.

Perit Dial Int. 2006 Jan-Feb;26(1):78-84.

10.

Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).

Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.

Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.

PMID:
19285609
12.

Risk of cardiovascular disease in kidney donors as a chronic kidney disease cohort.

Naganuma T, Takemoto Y, Taiyou O, Hirokazu T, Masaki M, Maeda S, Nakatani T.

Mol Med Rep. 2012 Jan;5(1):7-11. doi: 10.3892/mmr.2011.629. Epub 2011 Oct 12.

PMID:
21993905
13.

The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.

Pennell P, Leclercq B, Delahunty MI, Walters BA.

Clin Nephrol. 2006 Nov;66(5):336-47.

PMID:
17140163
14.

Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.

Bergesio F, Monzani G, Guasparini A, Ciuti R, Gallucci M, Cristofano C, Castrignano E, Cupisti A, Barsotti G, Marcucci R, Abbate R, Bandini S, Gallo M, Tosi PL, Salvadori M.

Clin Nephrol. 2005 Aug;64(2):103-12.

PMID:
16114786
15.

Slow progression of chronic kidney disease and what it is associated with.

Eftimovska N, Stojceva-Taneva O, Polenakovic M.

Prilozi. 2008 Jul;29(1):153-65.

PMID:
18709007
16.

[Hypertension in hemodialysis patients in Andalucia].

García Cortés MJ, Ceballos M; Grupo de tabajo sobre Calidad de la Hemodiálisis en Andalucía.

Nefrologia. 2004;24(2):149-57. Spanish.

17.

Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.

Hayashi SY, Rohani M, Lindholm B, Brodin LA, Lind B, Barany P, Alvestrand A, Seeberger A.

Nephrol Dial Transplant. 2006 Jan;21(1):125-32. Epub 2005 Oct 12.

18.

Association of cardiac valve calcification and inflammation in patients on hemodialysis.

Torun D, Sezer S, Baltali M, Adam FU, Erdem A, Ozdemir FN, Haberal M.

Ren Fail. 2005;27(2):221-6.

PMID:
15807189
20.

Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?

van der Velde M, Bello AK, Brantsma AH, El Nahas M, Bakker SJ, de Jong PE, Gansevoort RT.

Nephrol Dial Transplant. 2012 Jun;27(6):2275-83. doi: 10.1093/ndt/gfr634. Epub 2012 Jan 9.

Items per page

Supplemental Content

Write to the Help Desk